{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-084629","form_type":"8-K","ticker":null,"cik":"0001850079","company_name":"Telesis Bio Inc.","filed_at":"2024-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.909346+00:00","generated_at":"2026-05-31T19:49:32.387162+00:00","sec_items":["1.01","1.02","5.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Telesis Bio enters $5.85M promissory notes at 12% from major shareholders, repays MidCap debt, expands board","bullets":["Issued $5.85M promissory notes to Novalis and Northpond at 12% annual interest, maturing Jan 16, 2026.","Repaid $5.84M to MidCap Financial, terminating existing term and revolver loan agreements.","Board expanded from 8 to 13; five new directors appointed: Hlavinka, Golub, Hodges, Weissman, Krueger.","Side letter gives lenders board control: majority of nominating committee, replacement rights while >10% ownership.","Registration rights waiver defers liquidated damages and waives accrued interest for a set period."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-084629","json":"https://secwatch.observer/filing/0000950170-24-084629.json","markdown":"https://secwatch.observer/filing/0000950170-24-084629.md","text":"https://secwatch.observer/filing/0000950170-24-084629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/tbio-20240716.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:49:32.387162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28816e8ae0","claim":"Sarah Hlavinka was appointed as Director at Telesis Bio Inc..","evidence_excerpt":"appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3cf0be4956","claim":"James Weissman was appointed as Director at Telesis Bio Inc..","evidence_excerpt":"appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"41fa59dc5f","claim":"Todd Krueger was appointed as Director at Telesis Bio Inc..","evidence_excerpt":"appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8c20f875c4","claim":"Steve Golub was appointed as Director at Telesis Bio Inc..","evidence_excerpt":"appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8de4b08164","claim":"Michael Hodges was appointed as Director at Telesis Bio Inc..","evidence_excerpt":"appointed each of Sarah Hlavinka, Steve Golub, Michael Hodges, James Weissman, and Todd Krueger (collectively, the “New Directors”), as members of the Board to fill the five vacancies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000095017024084629/0000950170-24-084629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}